MoonLake Ownership & Insider Activity

MoonLake Immunotherapeutics

MLTXNASDAQ

$11.53

0.736.76%

Last update: Nov 6, 5:05 PM

Earnings: Q3 2026 Earnings were released on Wed Nov 4th, before the market open

MoonLake Ownership & Insider Activity - Benzinga

MoonLake (MLTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.8% of shares outstanding. Institutional investors hold 10.4%.

Shares Outstanding

85.107M

Shares Float

61.744M

Insider Shares Owned

4.098M

Insider % Owned

4.8%

Institutional Shares Held

8.864M

Institutional % Held

10.4%

Ownership Breakdown

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Jul 27, 2026	Kristian Reich	CHIEF SCIENTIFIC OFFICER	SELL	1.100K	$20.00	$22K
Jul 21, 2026	Kristian Reich	CHIEF SCIENTIFIC OFFICER	SELL	52.448K	$20.02	$1.0M
Jul 20, 2026	Kristian Reich	CHIEF SCIENTIFIC OFFICER	SELL	43.700K	$20.09	$878K
Jul 15, 2026	Kristian Reich	CHIEF SCIENTIFIC OFFICER	SELL	16.105K	$20.01	$322K
Jul 9, 2026	Jorge Santos da Silva	CHIEF EXECUTIVE OFFICER	SELL	102.225K	$20.02	$2.0M
Jul 1, 2026	Jorge Santos da Silva	CHIEF EXECUTIVE OFFICER	SELL	47.775K	$20.03	$957K
Jun 22, 2026	Matthias Bodenstedt	CHIEF FINANCIAL OFFICER	SELL	39.120K	$22.04	$862K
Jun 17, 2026	Matthias Bodenstedt	CHIEF FINANCIAL OFFICER	SELL	17.876K	$19.67	$352K
Jun 15, 2026	Kristian Reich	CHIEF SCIENTIFIC OFFICER	SELL	150.000K	$19.01	$2.9M
May 11, 2026	Matthias Bodenstedt	CHIEF FINANCIAL OFFICER	SELL	13.653K	$20.02	$273K